Glycogen Synthase Kinase 3 Inhibition Slows Mitochondrial Adenine Nucleotide Transport and Regulates Voltage-Dependent Anion Channel Phosphorylation

Inhibition of glycogen synthase kinase (GSK)-3 reduces ischemia/reperfusion injury by mechanisms that involve the mitochondria. The goal of this study was to explore possible molecular targets and mechanistic basis of this cardioprotective effect. In perfused rat hearts, treatment with GSK inhibitors before ischemia significantly improved recovery of function. To assess the effect of GSK inhibitors on mitochondrial function under ischemic conditions, mitochondria were isolated from rat hearts perfused with GSK inhibitors and were treated with uncoupler or cyanide or were made anoxic. GSK inhibition slowed ATP consumption under these conditions, which could be attributable to inhibition of ATP entry into the mitochondria through the voltage-dependent anion channel (VDAC) and/or adenine nucleotide transporter (ANT) or to inhibition of the F1F0-ATPase. To determine the site of the inhibitory effect on ATP consumption, we measured the conversion of ADP to AMP by adenylate kinase located in the intermembrane space. This assay requires adenine nucleotide transport across the outer but not the inner mitochondrial membrane, and we found that GSK inhibitors slow AMP production similar to their effect on ATP consumption. This suggests that GSK inhibitors are acting on outer mitochondrial membrane transport. In sonicated mitochondria, GSK inhibition had no effect on ATP consumption or AMP production. In intact mitochondria, cyclosporin A had no effect, indicating that ATP consumption is not caused by opening of the mitochondrial permeability transition pore. Because GSK is a kinase, we assessed whether protein phosphorylation might be involved. Therefore, we performed Western blot and 1D/2D gel phosphorylation site analysis using phos-tag staining to indicate proteins that had decreased phosphorylation in hearts treated with GSK inhibitors. Liquid chromatographic–mass spectrometric analysis revealed 1 of these proteins to be VDAC2. Taken together, we found that GSK-mediated signaling modulates transport through the outer membrane of the mitochondria. Both proteomics and adenine nucleotide transport data suggest that GSK regulates VDAC and that VDAC may be an important regulatory site in ischemia/reperfusion injury.

[1]  K. Heesom,et al.  Inhibition of Mitochondrial Permeability Transition Pore Opening by Ischemic Preconditioning Is Probably Mediated by Reduction of Oxidative Stress Rather Than Mitochondrial Protein Phosphorylation , 2008, Circulation research.

[2]  M. Mattson,et al.  The Identity and Regulation of the Mitochondrial Permeability Transition Pore , 2008, Annals of the New York Academy of Sciences.

[3]  A. Hsu,et al.  Delayed cardioprotection afforded by the glycogen synthase kinase 3 inhibitor SB-216763 occurs via a KATP- and MPTP-dependent mechanism at reperfusion. , 2008, American journal of physiology. Heart and circulatory physiology.

[4]  P. Ping,et al.  Past and present course of cardioprotection against ischemia-reperfusion injury. , 2007, Journal of applied physiology.

[5]  J. Ávila,et al.  Inhibition of Glycogen Synthase Kinase 3&bgr; During Heart Failure Is Protective , 2007, Circulation research.

[6]  D. Yellon,et al.  Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection , 2007, Heart Failure Reviews.

[7]  Michael V. Cohen,et al.  Signaling pathways in ischemic preconditioning , 2007, Heart Failure Reviews.

[8]  A. Hsu,et al.  GSK3β inhibition and KATP channel opening mediate acute opioid-induced cardioprotection at reperfusion , 2007, Basic Research in Cardiology.

[9]  W. Craigen,et al.  Voltage-dependent anion channels are dispensable for mitochondrial-dependent cell death , 2007, Nature Cell Biology.

[10]  M. Gladwin,et al.  Deoxymyoglobin Is a Nitrite Reductase That Generates Nitric Oxide and Regulates Mitochondrial Respiration , 2007, Circulation research.

[11]  B. Doble,et al.  Glycogen synthase kinase-3--an overview of an over-achieving protein kinase. , 2006, Current drug targets.

[12]  J. Soler‐Soler,et al.  Mitochondrial Ca2+ uptake during simulated ischemia does not affect permeability transition pore opening upon simulated reperfusion. , 2006, Cardiovascular research.

[13]  K. Shimamoto,et al.  Erythropoietin affords additional cardioprotection to preconditioned hearts by enhanced phosphorylation of glycogen synthase kinase-3 beta. , 2006, American journal of physiology. Heart and circulatory physiology.

[14]  C. Stein,et al.  A pharmacologic target of G3139 in melanoma cells may be the mitochondrial VDAC. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[15]  G. Gross,et al.  Ligand triggers of classical preconditioning and postconditioning. , 2006, Cardiovascular research.

[16]  Frank A Witzmann,et al.  Mitochondrial matrix phosphoproteome: effect of extra mitochondrial calcium. , 2006, Biochemistry.

[17]  J. Lemasters,et al.  Voltage-dependent anion channel (VDAC) as mitochondrial governator--thinking outside the box. , 2006, Biochimica et biophysica acta.

[18]  E. Murphy,et al.  Inhibition of GSK-3β as a target for cardioprotection: the importance of timing, location, duration and degree of inhibition , 2005, Expert opinion on therapeutic targets.

[19]  C. Thompson,et al.  Hexokinase-mitochondria interaction mediated by Akt is required to inhibit apoptosis in the presence or absence of Bax and Bak. , 2004, Molecular cell.

[20]  Michael D. Schneider,et al.  Transgenic Expression of Bcl-2 Modulates Energy Metabolism, Prevents Cytosolic Acidification During Ischemia, and Reduces Ischemia/Reperfusion Injury , 2004, Circulation research.

[21]  A. Terzic,et al.  Potassium channel openers are uncoupling protonophores: implication in cardioprotection , 2004, FEBS letters.

[22]  E. Olson,et al.  Glycogen synthase kinase-3β mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore , 2004 .

[23]  W. Koch,et al.  G Protein–Coupled Receptor Internalization Signaling Is Required for Cardioprotection in Ischemic Preconditioning , 2004, Circulation research.

[24]  A. Hsu,et al.  Opioid-Induced Cardioprotection Occurs via Glycogen Synthase Kinase β Inhibition During Reperfusion in Intact Rat Hearts , 2004, Circulation research.

[25]  S. Javadov,et al.  Mitochondrial permeability transition pore opening during myocardial reperfusion--a target for cardioprotection. , 2004, Cardiovascular research.

[26]  CharlesSteenbergen,et al.  Phosphorylation of Glycogen Synthase Kinase-3β During Preconditioning Through a Phosphatidylinositol-3-Kinase–Dependent Pathway Is Cardioprotective , 2002 .

[27]  E. Murphy,et al.  Phosphorylation of Glycogen Synthase Kinase-3&bgr; During Preconditioning Through a Phosphatidylinositol-3-Kinase–Dependent Pathway Is Cardioprotective , 2002, Circulation research.

[28]  J. Hoek,et al.  Mitochondrial Binding of Hexokinase II Inhibits Bax-induced Cytochrome c Release and Apoptosis* , 2002, The Journal of Biological Chemistry.

[29]  M. V. Vander Heiden,et al.  Bcl-x l Promotes the Open Configuration of the Voltage-dependent Anion Channel and Metabolite Passage through the Outer Mitochondrial Membrane* , 2001, The Journal of Biological Chemistry.

[30]  P. Bernardi,et al.  Opening of the Mitochondrial Permeability Transition Pore Causes Depletion of Mitochondrial and Cytosolic NAD+and Is a Causative Event in the Death of Myocytes in Postischemic Reperfusion of the Heart* , 2001, The Journal of Biological Chemistry.

[31]  W. Craigen,et al.  Altered Mitochondrial Sensitivity for ADP and Maintenance of Creatine-stimulated Respiration in Oxidative Striated Muscles from VDAC1-deficient Mice* , 2001, The Journal of Biological Chemistry.

[32]  M. V. Heiden,et al.  Outer mitochondrial membrane permeability can regulate coupled respiration and cell survival. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[33]  Masashi Narita,et al.  Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC , 1999, Nature.

[34]  V. Skulachev,et al.  High protonic potential actuates a mechanism of production of reactive oxygen species in mitochondria , 1997, FEBS letters.

[35]  D. Davison,et al.  A novel mouse mitochondrial voltage-dependent anion channel gene localizes to chromosome 8. , 1996, Genomics.

[36]  A. Halestrap,et al.  Mitochondrial non-specific pores remain closed during cardiac ischaemia, but open upon reperfusion. , 1995, The Biochemical journal.

[37]  P. Roach,et al.  A secondary phosphorylation of CREB341 at Ser129 is required for the cAMP-mediated control of gene expression. A role for glycogen synthase kinase-3 in the control of gene expression. , 1994, The Journal of biological chemistry.

[38]  J. Adelman,et al.  Cloning and functional expression in yeast of two human isoforms of the outer mitochondrial membrane channel, the voltage-dependent anion channel. , 1993, The Journal of biological chemistry.

[39]  R. Jennings,et al.  Effect of inhibition of the mitochondrial ATPase on net myocardial ATP in total ischemia. , 1991, Journal of molecular and cellular cardiology.

[40]  G. Brierley,et al.  Intravesicular pH changes in submitochondrial particles induced by monovalent cations: relationship to the Na+/H+ and K+/H+ antiporters. , 1988, Archives of biochemistry and biophysics.

[41]  P. Roach,et al.  Formation of protein kinase recognition sites by covalent modification of the substrate. Molecular mechanism for the synergistic action of casein kinase II and glycogen synthase kinase 3. , 1987, The Journal of biological chemistry.

[42]  R. Jennings,et al.  Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. , 1986, Circulation.

[43]  A. Beavis,et al.  Swelling and contraction of the mitochondrial matrix. I. A structural interpretation of the relationship between light scattering and matrix volume. , 1985, The Journal of biological chemistry.

[44]  J. Williamson,et al.  Analysis of control of glycolysis in ischemic hearts having heterogeneous zones of anoxia. , 1978, Journal of molecular and cellular cardiology.

[45]  J. Sadoshima,et al.  Inhibition of Glycogen Synthase Kinase 3 (cid:1) During Heart Failure Is Protective Integrative Physiology , 2007 .

[46]  M. Colombini.  VDAC: The channel at the interface between mitochondria and the cytosol , 2004, Molecular and Cellular Biochemistry.